Meier PP, Engstrom JL, Patel AL, Jegier BJ, Bruns NE. Improving the use of human milk during and after the NICU stay. Clin Perinatol 2010; 37: 217–245.
Jeurink PV, van Bergenhenegouwen J, Jimenez E, Knippels LM, Fernández L, Garssen J et al. Human milk: a source of more life than we imagine. Benef Microbes 2013; 4: 17–30.
Riskin A. Changes in immunomodulatory constituents of human milk in response to active infection in the nursing infant. Pediatr Res 2012; 71: 220–225.
Levy I, Comarsca J, Davidovits M, Klinger G, Sirota L, Linder N. Urinary tract infection in preterm infants: the protective role of breastfeeding. Pediatr Nephrol 2009; 24: 527–531.
Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk vs preterm formula. Pediatrics 1999; 103: 1150–1157.
Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O'Shea TM. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol 2007; 27: 428–433.
Furman L, Taylor G, Minich N, Hack M. The effect of maternal milk on neonatal morbidity of very low-birth-weight infants. Arch Pediatr Adolesc Med 2003; 157: 66–71.
Hurst NM. Recognizing and treating delayed or failed lactogenesis II. J Midwifery Womens Health 2007; 52: 588–594.
Dewey KG, Nommsen-Rivers LA, Heinig MJ, Cohen RJ. Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation, and excess neonatal weight loss. Pediatrics 2003; 112: 607–619.
Nommsen-Rivers LA, Dolan LM, Huang B. Timing of stage II lactogenesis is predicted by antenatal metabolic health in a cohort of primiparas. Breastfeed Med 2012; 7: 43–49.
Nommsen-Rivers LA, Chantry CJ, Peerson JM, Cohen RJ, Dewey KG. Delayed onset of lactogenesis among first-time mothers is related to maternal obesity and factors associated with ineffective breastfeeding. Am J Clin Nutr 2010; 92: 574–584.
Carroll K, Herrmann K. Introducing donor human milk to the NICU: lessons for Australia. Breastfeed Rev 2012; 20: 19–26.
Boyd CA, Quigley MA, Brocklehurst P. Donor breast milk versus infant formula for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2007; 92: F169–F175.
Arslanoglu S, Ziegler EE, Moro GE. WAPM Working Group on Nutrition. Donor human milk in preterm infant feeding: evidence and recommendations. J Perinat Med 2010; 38: 347–351.
Zuppa AA, Sindico P, Orchi C, Carducci C, Cardiello V, Romagnoli C. Safety and efficacy of galactogogues: substances that induce, maintain and increase breast milk production. J Pharm Pharmaceut Sci 2010; 13: 162–174.
Mannion C, Mansell D. Breastfeeding self-efficacy and the use of prescription medication: a pilot study. Obstet Gynecol Int 2012; 2012: 562704.
Marasco L. Increasing your milk supply with galactogogues. J Hum Lact 2008; 24: 455–456.
Academy of Breastfeeding Medicine Protocol Committee. ABM Clinical Protocol #9: Use of galactogogues in initiating or augmenting the rate of maternal milk secretion (first revision, January 2011). Breastfeed Med 2011; 6: 41–49.
Nordeng H, Havnen GC. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf 2004; 13: 371–380.
Puschner B, Galey FD, Holstege DM, Palazoglu M. Sweet clover poisoning in dairy cattle in California. J Am Vet Med Assoc 1998; 212: 857–859.
Carotenuto D, Di Pierro F. Studio sulla tollerabilità ed efficacia della silimarina BIO-C® (Piùlatte®) micronizzata come galattagogo. Acta Neonatol Pediatr 2005; 4: 393–340.
Vojtisek B. Milk Thistel (silybum marianum) in the feed of ketotik cow. Vet Med (Praha) 1991; 36: 321–330.
Kren V, Walterova D. Silybin and Silymarin – new effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005; 149: 29–41.
Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 2006; 124: 491–504.
Saxena BN, Shrimanker K, Grudzinskas JG. Levels of contraceptive steroids in breast milk and plasma of lactating women. Contraception 1977; 16: 605–613.
Garavaglia L, Galletti S, Tedesco D. Silymarin and lycopene administration in periparturient dairy cows: effects on milk production and oxidative status. NZ Vet J 2015; 63: 313–318.
Capasso R. Effect of Silitidil, a standardized extract of milk thistle, on the serum prolactin levels in female rats. Nat Prod Commun 2014; 9: 943–944.
Di Pierro F, Callegari A, Carotenuto D, Mollo Tapia M. Clinical efficacy, safety and tolerability of BIO-C (micronized Silymarin) as a galctogogue. Acta Biomed 2008; 79: 205–210.
Castoldi F, Pivetti V, Moiraghi L, Marangione P, Lista G. Sylimarin/galega administration in term and preterm mothers to sustain breast feeding: an observational study. Minerva Pediatr 2014; 66: 375–378.
Mortel M, Mehta SD. Systematic review of the efficacy of herbal galactogogues. J Hum Lact 2013; 29: 154.
Wilinska M, Schleußner E. Galactogogues and breastfeeding. Focus on new natural solutions for hypogalactia. Nutrafoods 2015; 14: 119–125.
Ahrabi AF, Schanler RJ. Human milk is the only milk for premies in the NICU! Early Hum Dev 2013; 89: S51–S53.
Schanker RJ. The use of human milk for premature infants. Pediatr Clin North Am 2001; 48: 207–219.
Lee J, Kim H-S, Jung YH, Choi KY, Shin SH, Kim E-K et al. Oropharyngeal colostrum administration in extremely premature infants: an RCT. Pediatrics 2015; 135: e357.
Tedesco D, Tava A, Galletti S, Tameni M, Varisco G, Costa et al. Effects of silymarin, a natural hepatoprotector, in periparturient dairy cows. J Dairy Sci 2004; 87: 2239–2247.
Siegel AB, Stebbing J. Milk thistle: early seeds of potential. Lancet Oncol 2013; 14: 929–930.
Mayer KE, Myers RP, Lee SS. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepatitis 2005; 12: 559–567.